Carbamazepine-induced hepatitis in a patient with cervical myelopathy

Archives of Physical Medicine and Rehabilitation

Volumn 77, Issue 3, 1996, Pages 305-306

  Kong, Keng He ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

AGED; ARTICLE; CASE REPORT; CERVICAL MYELOPATHY; CHOLESTASIS; CLINICAL FEATURE; DEGENERATIVE DISEASE; DRUG INDUCED DISEASE; DYSESTHESIA; EOSINOPHILIA; HEPATITIS; HUMAN; MALE; MUSCLE WEAKNESS; RASH;

EID: 0029968792     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(96)90117-3     Document Type: Article

References (6)

1. Rail TW, Schleifer LS. Drugs effective in the therapy of epilepsies. In: Gilman AG, Rall TW, Niles AS, Taylor P, editors. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, 1992:436-62.
2. Mitchell MC, Boitnott JK, Arregui A, Maddrey WC. Granulomatous hepatitis associated with carbamazepine therapy. Am J Med 1981;71:733-5.
3. Levander HG. Granulomatous hepatitis in a patient receiving carbamazepine. Acta Med Scand 1980;208:333-5.
4. Levy M, Goodman MW, Van Dyne BJ, Sumner HW. Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med 1981;95:64-5.
5. Weinberger J, Nicklas WJ, Berl S. Mechanism of action of anticonvulsants. Neurology 1976;26:162-73.
6. Zucker P, Daum F, Cohen MI. Fatal carbamazepine hepatitis. J Pediatr 1977;91:667-8.